BMC CLINICAL PATHOLOGY, vol.14, 2014 (Peer-Reviewed Journal)
Article / Article
BMC CLINICAL PATHOLOGY
Emerging Sources Citation Index, Scopus
Tumor immunology, Cancer stem cells, Autologous antibody responses, Tumor antigens, Lung cancer, Immunohistochemistry, Autologous antibodies, Cancer stem-cells
Background: Anti-SOX2 antibody responses are observed in about 10 to 20% of small cell lung cancer (SCLC) patients. The aim of this study was to determine whether such responses reflect a particular pattern of SOX2 protein expression in the tumor and whether this pattern associates with clinical outcome.